PURE on OTC

PURE BIOSCIENCE, INC.

American miscellaneous chemical products company, incorporated in Delaware. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

$2.2MRevenue, fiscal 20252
-$2.4MNet income, fiscal 20252

Compare with ASP Isotopes Inc., FLEXIBLE SOLUTIONS INTERNATIONAL INC or Arq, Inc., or pick any stock.

  • TickerPURE on OTC1
  • IndustryMiscellaneous Chemical Products1
  • HeadquartersEl Cajon, California1
  • Incorporated inDE3
  • Business address771 Jamacha Road #512, El Cajon, Ca 920193
  • Filer categoryNon-accelerated filer, Smaller reporting company3

Savings: Utilizing distributors can reduce overhead costs associated with logistics, warehousing, and inventory management.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

59.2%Gross margin2
-103.2%Operating margin2
-108.9%Net margin2
12.2%Revenue growth, 20252

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue20¢$899.0K
  • Research and development7¢$316.0K
  • Selling, general and admin73¢$3.3M

Out of $2.2M in revenue.2 The company lost money this year.

Financial statements

Revenue56789102$2.2M in 2025+24% since 2018
0$2.0M$4.0M$6.0M$8.0M2018: $1.8M$1.8M20182019: $1.9M$1.9M2019+8%2020: $6.9M$6.9M2020+262%2021: $3.9M$3.9M2021−43%2022: $1.9M$1.9M2022−53%2023: $1.9M$1.9M2023+1%2024: $2.0M$2.0M2024+5%2025: $2.2M$2.2M2025+12%
Gross profit6789102$1.3M in 2025+10% since 2019
0$2.0M$4.0M$6.0M2019: $1.2M$1.2M20192020: $4.0M$4.0M2020+240%2021: $2.1M$2.1M2021−48%2022: $1.0M$1.0M2022−52%2023: $971.0K$971.0K2023−3%2024: $1.2M$1.2M2024+19%2025: $1.3M$1.3M2025+13%
Operating income56789102-$2.3M in 2025−68% since 2018
-$8.0M-$6.0M-$4.0M-$2.0M0$2.0M2018: -$7.0M-$7.0M20182019: -$5.6M-$5.6M2019−21%2020: $4.0K$4.0K20202021: -$2.3M-$2.3M20212022: -$3.7M-$3.7M2022+61%2023: -$3.9M-$3.9M2023+6%2024: -$3.2M-$3.2M2024−19%2025: -$2.3M-$2.3M2025−29%
Net income56789102-$2.4M in 2025−68% since 2018
-$8.0M-$6.0M-$4.0M-$2.0M0$2.0M2018: -$7.4M-$7.4M20182019: -$6.6M-$6.6M2019−12%2020: $4.0K$4.0K20202021: -$2.3M-$2.3M20212022: -$3.5M-$3.5M2022+51%2023: -$4.0M-$4.0M2023+13%2024: -$3.4M-$3.4M2024−15%2025: -$2.4M-$2.4M2025−28%
Fiscal year20182019202020212022202320242025
Revenue$1.8M5$1.9M6$6.9M7$3.9M8$1.9M9$1.9M10$2.0M2$2.2M2
Cost of revenue$763.0K5$728.0K6$2.9M7$1.9M8$853.0K9$906.0K10$811.0K2$899.0K2
Gross profit$1.2M6$4.0M7$2.1M8$1.0M9$971.0K10$1.2M2$1.3M2
Research and development$459.0K5$354.0K6$322.0K7$339.0K8$319.0K9$297.0K10$302.0K2$316.0K2
Selling, general and admin$5.2M5$6.4M6$3.7M7$4.0M8$4.1M9$4.3M10$4.0M2$3.3M2
Operating expenses$4.7M9$4.9M10$4.3M2$3.6M2
Operating income-$7.0M5-$5.6M6$4.0K7-$2.3M8-$3.7M9-$3.9M10-$3.2M2-$2.3M2
Interest$8.0K5$6.0K6$5.0K7$4.0K8$6.0K9$14.0K9
Income tax$1.6K5$1.6K6$1.6K7$1.6K8$1.6K9$010$02$02
Net income-$7.4M5-$6.6M6$4.0K7-$2.3M8-$3.5M9-$4.0M10-$3.4M2-$2.4M2
Earnings per share-$0.096$0.007-$0.038-$0.049-$0.0410-$0.032-$0.022
Earnings per share (diluted)-$0.096$0.007-$0.037-$0.049-$0.0410-$0.032-$0.022
Shares (weighted, basic)88.8M shares9111.4M shares10111.9M shares2111.9M shares2
Shares (weighted, diluted)88.8M shares9111.4M shares10111.9M shares2111.9M shares2

Compare PURE BIOSCIENCE, INC. with another company

Leadership

Who has led PURE BIOSCIENCE, INC., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (27)

Former names

  • PURE BIOSCIENCEOct 29, 2003 to Mar 17, 20113
  • INNOVATIVE MEDICAL SERVICESJul 5, 1996 to Sep 2, 20033

Timeline

  1. Mar 22, 2023New chief executive Robert F. Bartlett becomes CEO15
  2. Sep 25, 2013New chief executive Henry R. Lambert becomes CEO16
  3. Apr 14, 2006New chief executive Michael L. Krall becomes CEO17

Filings

95 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 34 major events, 32 insider forms, 9 other. The latest 20:

  1. Jun 15, 202610-Q EDGAR
  2. Jun 15, 20268-K EDGAR
  3. May 5, 20268-K EDGAR
  4. Mar 17, 202610-Q EDGAR
  5. Mar 17, 20268-K EDGAR
  6. Feb 20, 20268-K EDGAR
  7. Dec 30, 2025DEF 14A EDGAR
  8. Dec 18, 2025PRE 14A EDGAR
  9. Dec 15, 202510-Q EDGAR
  10. Dec 15, 20258-K EDGAR
  11. Nov 28, 20253 EDGAR
  12. Nov 19, 20258-K EDGAR
  13. Oct 29, 202510-K EDGAR
  14. Oct 29, 20258-K EDGAR
  15. Jun 16, 202510-Q EDGAR
  16. Jun 16, 20258-K EDGAR
  17. Mar 17, 202510-Q EDGAR
  18. Mar 17, 20258-K EDGAR
  19. Jan 28, 20258-K EDGAR
  20. Dec 16, 202410-Q EDGAR

The 95 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

6 open-market trades by officers, directors and large owners since October 2021: 6 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 22, 2023BARTLETT ROBERT FCEO and PresidentBuy50,000$0.16$8.0KForm 4
Mar 21, 2023Blotner BernardDirectorBuy10,000$0.13$1.3KForm 4
Dec 15, 2022Lee Tom YDirectorBuy50,000$0.13$6.5KForm 4
Mar 21, 2022Lee Tom YDirectorBuy185,000$0.20$37.0KForm 4
Mar 17, 2022Lee Tom YDirectorBuy13,250$0.18$2.4KForm 4
Mar 16, 2022Lee Tom YDirectorBuy21,227$0.18$3.8KForm 4

From Forms 4 filed with the SEC.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49